Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thierry VandenDriessche

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Human Gene Therapy|June 8, 2012
Recent progress in gene therapy for hemophiliaMarinee K Chuah, Nisha Nair, Thierry VandenDriessche
Current Gene Therapy|December 20, 2003
Biosafety of onco-retroviral vectorsThierry VandenDriessche, Désiré Collen, Marinee K L Chuah
Current Opinion in Hematology|July 27, 2010
Preclinical and clinical progress in hemophilia gene therapyJanka Mátrai, Marinee K L Chuah, Thierry VandenDriessche
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 21, 2010
Recent advances in lentiviral vector development and applicationsJanka Mátrai, Marinee K L Chuah, Thierry VandenDriessche
Cardiovascular Research|August 5, 2015
Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translationMelvin Y Rincon, Thierry VandenDriessche, Marinee K Chuah
Current Gene Therapy|December 20, 2003
Biosafety of adenoviral vectorsMarinee K L Chuah, Désiré Collen, Thierry VandenDriessche
Seminars in Thrombosis and Hemostasis|May 1, 2004
Preclinical gene therapy studies for hemophilia using adenoviral vectorsLieven Thorrez, Thierry VandenDriessche, Désiré Collen, et al.
Methods in Enzymology|March 9, 2002
Oncoretroviral and lentiviral vector-mediated gene therapyThierry VandenDriessche, Luigi Naldini, Desire Collen, et al.
Bioscience Reports|November 2, 2017
Preclinical and clinical advances in transposon-based gene therapyJaitip Tipanee, Yoke Chin Chai, Thierry VandenDriessche, et al.
Human Gene Therapy|September 6, 2023
Hemophilia Gene Therapy: The End of the Beginning?Dries De Wolf, Kshitiz Singh, Marinee K Chuah, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Human Gene Therapy|June 8, 2012
Recent progress in gene therapy for hemophiliaMarinee K Chuah, Nisha Nair, Thierry VandenDriessche
Current Gene Therapy|December 20, 2003
Biosafety of onco-retroviral vectorsThierry VandenDriessche, Désiré Collen, Marinee K L Chuah
Current Opinion in Hematology|July 27, 2010
Preclinical and clinical progress in hemophilia gene therapyJanka Mátrai, Marinee K L Chuah, Thierry VandenDriessche
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 21, 2010
Recent advances in lentiviral vector development and applicationsJanka Mátrai, Marinee K L Chuah, Thierry VandenDriessche
Cardiovascular Research|August 5, 2015
Gene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translationMelvin Y Rincon, Thierry VandenDriessche, Marinee K Chuah
Current Gene Therapy|December 20, 2003
Biosafety of adenoviral vectorsMarinee K L Chuah, Désiré Collen, Thierry VandenDriessche
Seminars in Thrombosis and Hemostasis|May 1, 2004
Preclinical gene therapy studies for hemophilia using adenoviral vectorsLieven Thorrez, Thierry VandenDriessche, Désiré Collen, et al.
Methods in Enzymology|March 9, 2002
Oncoretroviral and lentiviral vector-mediated gene therapyThierry VandenDriessche, Luigi Naldini, Desire Collen, et al.
Bioscience Reports|November 2, 2017
Preclinical and clinical advances in transposon-based gene therapyJaitip Tipanee, Yoke Chin Chai, Thierry VandenDriessche, et al.
Human Gene Therapy|September 6, 2023
Hemophilia Gene Therapy: The End of the Beginning?Dries De Wolf, Kshitiz Singh, Marinee K Chuah, et al.
Pageof 9